Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 129 Pages
Report ld: 3481480
Request Sample
Customized Report
Implanted Urinary Incontinence Device Market Size(US$)

CAGR 2025-2031
8%
Market Size,2031
USD 2,033
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Implanted Urinary Incontinence Device was estimated to be worth US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 2033 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Implanted Urinary Incontinence Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Implanted Urinary Incontinence Device by region & country, by Type, and by Application.
The Implanted Urinary Incontinence Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implanted Urinary Incontinence Device.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Implanted Urinary Incontinence Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Implanted Urinary Incontinence Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Implanted Urinary Incontinence Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Implanted Urinary Incontinence Device Product Introduction
1.2 Global Implanted Urinary Incontinence Device Market Size Forecast
1.2.1 Global Implanted Urinary Incontinence Device Sales Value (2020-2031)
1.2.2 Global Implanted Urinary Incontinence Device Sales Volume (2020-2031)
1.2.3 Global Implanted Urinary Incontinence Device Sales Price (2020-2031)
1.3 Implanted Urinary Incontinence Device Market Trends & Drivers
1.3.1 Implanted Urinary Incontinence Device Industry Trends
1.3.2 Implanted Urinary Incontinence Device Market Drivers & Opportunity
1.3.3 Implanted Urinary Incontinence Device Market Challenges
1.3.4 Implanted Urinary Incontinence Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Implanted Urinary Incontinence Device Players Revenue Ranking (2024)
2.2 Global Implanted Urinary Incontinence Device Revenue by Company (2020-2025)
2.3 Global Implanted Urinary Incontinence Device Players Sales Volume Ranking (2024)
2.4 Global Implanted Urinary Incontinence Device Sales Volume by Company Players (2020-2025)
2.5 Global Implanted Urinary Incontinence Device Average Price by Company (2020-2025)
2.6 Key Manufacturers Implanted Urinary Incontinence Device Manufacturing Base and Headquarters
2.7 Key Manufacturers Implanted Urinary Incontinence Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Implanted Urinary Incontinence Device
2.9 Implanted Urinary Incontinence Device Market Competitive Analysis
2.9.1 Implanted Urinary Incontinence Device Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Implanted Urinary Incontinence Device Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implanted Urinary Incontinence Device as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Artificial Urinary Sphincters
3.1.2 Electrical Stimulation Devices
3.1.3 Others
3.2 Global Implanted Urinary Incontinence Device Sales Value by Type
3.2.1 Global Implanted Urinary Incontinence Device Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Implanted Urinary Incontinence Device Sales Value, by Type (2020-2031)
3.2.3 Global Implanted Urinary Incontinence Device Sales Value, by Type (%) (2020-2031)
3.3 Global Implanted Urinary Incontinence Device Sales Volume by Type
3.3.1 Global Implanted Urinary Incontinence Device Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Implanted Urinary Incontinence Device Sales Volume, by Type (2020-2031)
3.3.3 Global Implanted Urinary Incontinence Device Sales Volume, by Type (%) (2020-2031)
3.4 Global Implanted Urinary Incontinence Device Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Ambulatory Surgery Centres
4.1.3 Others
4.2 Global Implanted Urinary Incontinence Device Sales Value by Application
4.2.1 Global Implanted Urinary Incontinence Device Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Implanted Urinary Incontinence Device Sales Value, by Application (2020-2031)
4.2.3 Global Implanted Urinary Incontinence Device Sales Value, by Application (%) (2020-2031)
4.3 Global Implanted Urinary Incontinence Device Sales Volume by Application
4.3.1 Global Implanted Urinary Incontinence Device Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Implanted Urinary Incontinence Device Sales Volume, by Application (2020-2031)
4.3.3 Global Implanted Urinary Incontinence Device Sales Volume, by Application (%) (2020-2031)
4.4 Global Implanted Urinary Incontinence Device Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Implanted Urinary Incontinence Device Sales Value by Region
5.1.1 Global Implanted Urinary Incontinence Device Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Implanted Urinary Incontinence Device Sales Value by Region (2020-2025)
5.1.3 Global Implanted Urinary Incontinence Device Sales Value by Region (2026-2031)
5.1.4 Global Implanted Urinary Incontinence Device Sales Value by Region (%), (2020-2031)
5.2 Global Implanted Urinary Incontinence Device Sales Volume by Region
5.2.1 Global Implanted Urinary Incontinence Device Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Implanted Urinary Incontinence Device Sales Volume by Region (2020-2025)
5.2.3 Global Implanted Urinary Incontinence Device Sales Volume by Region (2026-2031)
5.2.4 Global Implanted Urinary Incontinence Device Sales Volume by Region (%), (2020-2031)
5.3 Global Implanted Urinary Incontinence Device Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Implanted Urinary Incontinence Device Sales Value, 2020-2031
5.4.2 North America Implanted Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Implanted Urinary Incontinence Device Sales Value, 2020-2031
5.5.2 Europe Implanted Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Implanted Urinary Incontinence Device Sales Value, 2020-2031
5.6.2 Asia Pacific Implanted Urinary Incontinence Device Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Implanted Urinary Incontinence Device Sales Value, 2020-2031
5.7.2 South America Implanted Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Implanted Urinary Incontinence Device Sales Value, 2020-2031
5.8.2 Middle East & Africa Implanted Urinary Incontinence Device Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Implanted Urinary Incontinence Device Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Implanted Urinary Incontinence Device Sales Value
6.2.1 Key Countries/Regions Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.2.2 Key Countries/Regions Implanted Urinary Incontinence Device Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.3.2 United States Implanted Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Implanted Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.4.2 Europe Implanted Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Implanted Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.5.2 China Implanted Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.5.3 China Implanted Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.6.2 Japan Implanted Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Implanted Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.7.2 South Korea Implanted Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Implanted Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.8.2 Southeast Asia Implanted Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Implanted Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Implanted Urinary Incontinence Device Sales Value, 2020-2031
6.9.2 India Implanted Urinary Incontinence Device Sales Value by Type (%), 2024 VS 2031
6.9.3 India Implanted Urinary Incontinence Device Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Boston Scientific Implanted Urinary Incontinence Device Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 GT Urological
7.2.1 GT Urological Company Information
7.2.2 GT Urological Introduction and Business Overview
7.2.3 GT Urological Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 GT Urological Implanted Urinary Incontinence Device Product Offerings
7.2.5 GT Urological Recent Development
7.3 RBM-Med
7.3.1 RBM-Med Company Information
7.3.2 RBM-Med Introduction and Business Overview
7.3.3 RBM-Med Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 RBM-Med Implanted Urinary Incontinence Device Product Offerings
7.3.5 RBM-Med Recent Development
7.4 ZEPHYR Surgical Implants
7.4.1 ZEPHYR Surgical Implants Company Information
7.4.2 ZEPHYR Surgical Implants Introduction and Business Overview
7.4.3 ZEPHYR Surgical Implants Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 ZEPHYR Surgical Implants Implanted Urinary Incontinence Device Product Offerings
7.4.5 ZEPHYR Surgical Implants Recent Development
7.5 Albyn Medical
7.5.1 Albyn Medical Company Information
7.5.2 Albyn Medical Introduction and Business Overview
7.5.3 Albyn Medical Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Albyn Medical Implanted Urinary Incontinence Device Product Offerings
7.5.5 Albyn Medical Recent Development
7.6 Implantica
7.6.1 Implantica Company Information
7.6.2 Implantica Introduction and Business Overview
7.6.3 Implantica Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Implantica Implanted Urinary Incontinence Device Product Offerings
7.6.5 Implantica Recent Development
7.7 Medtronic
7.7.1 Medtronic Company Information
7.7.2 Medtronic Introduction and Business Overview
7.7.3 Medtronic Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Medtronic Implanted Urinary Incontinence Device Product Offerings
7.7.5 Medtronic Recent Development
7.8 InControl Medical
7.8.1 InControl Medical Company Information
7.8.2 InControl Medical Introduction and Business Overview
7.8.3 InControl Medical Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 InControl Medical Implanted Urinary Incontinence Device Product Offerings
7.8.5 InControl Medical Recent Development
7.9 Atlantic Therapeutics Group
7.9.1 Atlantic Therapeutics Group Company Information
7.9.2 Atlantic Therapeutics Group Introduction and Business Overview
7.9.3 Atlantic Therapeutics Group Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Atlantic Therapeutics Group Implanted Urinary Incontinence Device Product Offerings
7.9.5 Atlantic Therapeutics Group Recent Development
7.10 Axonics Modulation Technologies
7.10.1 Axonics Modulation Technologies Company Information
7.10.2 Axonics Modulation Technologies Introduction and Business Overview
7.10.3 Axonics Modulation Technologies Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Axonics Modulation Technologies Implanted Urinary Incontinence Device Product Offerings
7.10.5 Axonics Modulation Technologies Recent Development
7.11 Laborie
7.11.1 Laborie Company Information
7.11.2 Laborie Introduction and Business Overview
7.11.3 Laborie Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Laborie Implanted Urinary Incontinence Device Product Offerings
7.11.5 Laborie Recent Development
7.12 Micron Medical
7.12.1 Micron Medical Company Information
7.12.2 Micron Medical Introduction and Business Overview
7.12.3 Micron Medical Implanted Urinary Incontinence Device Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Micron Medical Implanted Urinary Incontinence Device Product Offerings
7.12.5 Micron Medical Recent Development
8 Industry Chain Analysis
8.1 Implanted Urinary Incontinence Device Industrial Chain
8.2 Implanted Urinary Incontinence Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Implanted Urinary Incontinence Device Sales Model
8.5.2 Sales Channel
8.5.3 Implanted Urinary Incontinence Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Implanted Urinary Incontinence Device was estimated to be worth US$ 1281 million in 2025 and is projected to reach US$ 2180 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 145
USD 3950.00
(Single User License)
The global Implanted Urinary Incontinence Device market was valued at US$ 1281 million in 2025 and is anticipated to reach US$ 2180 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 126
USD 2900.00
(Single User License)
The global Implanted Urinary Incontinence Device market size was US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 2033 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 96
USD 4250.00
(Single User License)
The global Implanted Urinary Incontinence Device market is projected to grow from US$ 1195 million in 2024 to US$ 2033 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 159
USD 4900.00
(Single User License)
The global market for Implanted Urinary Incontinence Device was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 2033 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published Date: 2025-01-16
Pages: 96
USD 2900.00
(Single User License)
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
Published Date: 2024-04-12
Pages: 113
USD 4900.00
(Single User License)
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
Published Date: 2024-01-10
Pages: 124
USD 3950.00
(Single User License)
The global market for Implanted Urinary Incontinence Device was estimated to be worth US$ 1281 million in 2025 and is projected to reach US$ 2180 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 145
The global Implanted Urinary Incontinence Device market was valued at US$ 1281 million in 2025 and is anticipated to reach US$ 2180 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 126
The global Implanted Urinary Incontinence Device market size was US$ 1195 million in 2024 and is forecast to a readjusted size of US$ 2033 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 96
The global Implanted Urinary Incontinence Device market is projected to grow from US$ 1195 million in 2024 to US$ 2033 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 159
The global market for Implanted Urinary Incontinence Device was valued at US$ 1195 million in the year 2024 and is projected to reach a revised size of US$ 2033 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published: 2025-01-16
Pages: 96
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
Published: 2024-04-12
Pages: 113
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
Published: 2024-01-17
Pages: 89
Urinary incontinence is the involuntary loss of urine due to a loss of bladder control. Millions of people across the world are affected by urinary incontinence, and women are more likely to be affected than men. Urinary incontinence is highly underreported, primarily due to embarrassment to speak about it. Several factors such as urinary tract infection, weakening of the pelvic floor muscles and urethral sphincters, menopause, pregnancy and childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence.
Published: 2024-01-10
Pages: 124
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now